News Features ‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings Michael O'Riordan September 17, 2025
News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Features A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts Shelley Wood July 07, 2022
News Features World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard Shelley Wood December 13, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Features Cardiology After COVID-19: Physicians Predict Lasting Change Yael L. Maxwell May 20, 2020
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Features ESC Heart Failure 2019 At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback Shelley Wood May 30, 2019
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016